glp 1 agonist benefits In patients with #obesity, incretin-based therapies such as GLP-1 receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular Could GLP-1 Receptor Agonists Help
Description
470 In this trial, semaglutide benefited patients with heart failure and preserved ejection fraction by intervening with upstream metabolic drivers
This idea was bolstered by a series of experiments conducted between 1890 and 1905 by Marcel Eugne mile Gley, a French physiologist
Meier, J
Recent reviews note the need for careful monitoring of cardiometabolic effects, particularly since long-term safety data in adolescents are still emerging
